Table of contents

Abstracts from the Association of British Neurologists Annual Meeting 2011

• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1130 White matter lesions in familial Alzheimer's disease: evidence for influence of mutation position on amyloid angiopathy? (9 February, 2012)

  N Ryan, G Biessels, A Bastos-Leite, J Beck, S Mead, H Morris, J M Schott, M N Rossor, N C Fox
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1142 The neural basis of impaired self-awareness after traumatic brain injury (9 February, 2012)

  T Ham, V Bonnelle, T Barber, R Leech, K Kinnunen, X De Boissezon, R Greenwood, D J Sharp
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1154 The utility of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in Parkinson's disease (9 February, 2012)

  P McColgan, J Evans, D P Breen, S L Mason, B Ghosh, T Rittman, J Rowe, P Nestor, R A Barker, C H Williams-Gray
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1218 Frontal lobe activity during memory encoding in temporal lobe epilepsy (9 February, 2012)

  M Sidhu, J Stretton, G Winston, C Vollmar, S Bonelli, P Thompson, M Koepp, J S Duncan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1130 The neurological sequelae of the measles outbreak in South Africa (9 February, 2012)

  C Albertyn, D Hardie, H Van der Plas, S Candy, E Lee Pan, J Heckmann
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1206 Evaluation of a regional community-based epilepsy programme in Swaziland (9 February, 2012)

  L Bernstein, H Ford, W Welfare, B Dube
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1218 HIV distal sensory polyneuropathy in Sub-Saharan Africa: an evolving epidemic (9 February, 2012)

  D Bargiela, S Mullin, S Kalluvya, H Manji
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1030 Population-based study of white matter changes in TIA and stroke: relation to aetiological subtype, risk factors, biomarkers and prognosis (9 February, 2012)

  M Simoni, H Segal, A I Burgess, D Poole, Z Mehta, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1042 Evidence of substantial under-recognition of posterior circulation TIA: implications for definition (9 February, 2012)

  N L M Paul, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1054 Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study (9 February, 2012)

  N L M Paul, S Koton, O C Geraghty, R Luengo-Fernandez, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1106 Difference in vascular risk factor profile between Ischaemic strokes of undetermined aetiology and other stroke subtypes: population-based study and meta-analysis (9 February, 2012)

  L Li, N L M Paul, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1118 Outcome of endovascular treatment for symptomatic vertebral artery stenosis: experience in two neurosciences centres (9 February, 2012)

  U Schulz, F Kennedy, W Kueker, A Clifton, P Rothwell, H Markus
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1130 Read-right: free web-based therapy for stroke patients with alexia (9 February, 2012)

  A Leff, Y H Ong, M M Brown, G T Plant, M Husain
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1142 Population-based study of temporal trends in atrial fibrillation related incident ischaemic stroke: evidence of substantial failure of primary prevention (9 February, 2012)

  G Yiin, Z Mehta, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1030 Charcot-Marie-tooth disease: genetic diagnoses in a specialist clinic (9 February, 2012)

  S Murphy, A Pandraud, Y Liu, K Fawcett, J M Polke, G Davidson, M Laura, M Davis, H Houlden, M M Reilly
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1042 Hereditary sensory and autonomic neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases (9 February, 2012)

  L Matilde, F Eichler, T Hornemann, S M Murphy, J Polke, K Bull, H Houlden, M M Reilly
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1106 The clinical phenotypic spectrum of GFPT1 associated congenital myasthenic syndrome (9 February, 2012)

  A Chaouch, J S Mueller, V Guergueltcheva, F Muntoni, K Bushby, V Straub, J Palace, D Beeson, A Abicht, H Lochmuller
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1118 Are MND patients pre-morbidly fitter? Indirect evidence from hospital record-linkage (9 February, 2012)

  M Turner, C Wotton, K Talbot, M J Goldacre
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1130 Clinical features and clinical course of sporadic inclusion body myositis (IBM): a prospective cohort study: IBM-net (9 February, 2012)

  A Cortese, P Machado, A Miller, S Brady, D Hilton-Jones, J Morrow, A Hiscock, E Dewar, M Parton, M Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1142 Mexiletine is an effective treatment in non-dystrophic myotonia (9 February, 2012)

  D Raja Rayan, R J Barohn, B Bundy, Y Wang, L Herbelin, J Trivedi, S Venance, G Meola, R C Griggs, M G Hanna, CINCH Study Group
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1154 Skeletal muscle chloride channel gene (CLCN1) copy number variation can cause myotonia congenita (9 February, 2012)

  D Raja Rayan, A Haworth, R Sud, E Matthews, D Fialho, J Burge, S Portaro, A Toscano, M D Davis, M G Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1600 The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders (9 February, 2012)

  P Maddison, M J Titulaer, J J G Verschuuren, P Gozzard, B Lang, N Willcox, A Vincent, S R Irani, C J Chapman
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1612 Combinatorial glycoarray detects diverse new antibody specificities in Guillain-BarrÉ syndrome (9 February, 2012)

  S Rinaldi, K M Brennan, G Kalna, C Walgaard, B C Jacobs, R K Yu, H J Willison
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1636 Intravenous immunoglobulin to treat Japanese encephalitis; a randomised controlled trial in Nepalese children (9 February, 2012)

  S Nightingale, A Rayamajhi, N Bhatta, E Ledger, M Griffiths, L Turtle, R Singh, S Galbraith, P Poudel, T Solomon
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1648 Raised levels of interleukin 1β, interleukin 1 receptor antagonist and G-CSF predict fatality among encephalitis patients infected with enterovirus 71 (9 February, 2012)

  M Griffiths, M H Ooi, S C Wong, A Mohan, Y Podin, D Perera, C H Chieng, P H Tio, M J Cardosa, T Solomon
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1700 Expanding the phenotypic spectrum of progressive encephalomyelitis with rigidity and myoclonus syndrome (PERMS) associated with glycine receptor antibody: clinical and laboratory study of 20 patients (9 February, 2012)

  M I Leite, P Waters, A Carvajal, M Woodhall, A Vincent
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1600 Treatment of essential tremor: report on 200 patients (9 February, 2012)

  P Bain, Y Nigmatullina
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1612 Sporadic AOPTD is a genetic disorder: evidence from the temporal discrimination threshold (9 February, 2012)

  O Kimmich, D Bradley, R Whelan, N Mulrooney, R B Reilly, S Hutchinson, S O'Riordan, M Hutchinson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1624 Myoclonus dystonia: a clinical and genetic description (9 February, 2012)

  K Peall, A J Waite, M A Kurian, T Hedderly, M Smith, J P Lin, T T Warner, H Pall, P Chinnery, A Whone, M J Owen, D J Blake, H R Morris
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1636 Prevalence of mutations in parkin, PINK1, DJ-1 and LRRK2 in early onset Parkinson's Disease: a UK based study and systematic review (9 February, 2012)

  H Morris, J P Pearson, L L Kilarski, M M Wickremaratchi, M D W Knipe, V Newsway, N M Williams, Y Ben-Shlomo, UK Early Onset Parkinson's disease group
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1648 Could laterality of diffusion measures prove useful in determining the lateralisation of non-lesional temporal lobe epilepsy? (9 February, 2012)

  G Winston, J Stretton, M Sidhu, M R Symms, J S Duncan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 1700 MRI quantification of lower limb muscle fatty atrophy: a potential outcome measure in chronic neuromuscular diseases (9 February, 2012)

  J Morrow, C D J Sinclair, A Fischmann, J S Thornton, T A Yousry, M M Reilly, M G Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0830 A population-based study of paediatric onset multiple sclerosis (9 February, 2012)

  K Liang, K E Baker, M D Cossburn, G Ingram, C L Hirst, T P Pickersgill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0842 Myelin-oligodendrocyte glycoprotein antibody as a cause of acute disseminated encephalomyelitis with a neuromyelitis optica-like phenotype in adults (9 February, 2012)

  J Kitley, M Woodhall, P Waters, M I Leite, E Devenney, J Craig, A Vincent, J Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0854 The sensitivity of JC virus DNA detection vs JC virus antibody testing in a natalizumab-treated group of relapsing MS patients (9 February, 2012)

  K Kinsella, S B Kelly, C F DeGascun, M Carr, M Duggan, M Hutchinson, N Tubridy, C McGuigan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0918 Amiloride treatment ameliorates MRI surrogate markers of neurodegeneration in primary progressive multiple sclerosis (9 February, 2012)

  T Arun, E Sbdarella, M Ruiter, V Tomassini, M I Leite, M Craner, L Fugger, M Jenkinson, J Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0930 A single 7T MRI brain scan accurately predicts eventual diagnosis of MS in cases with initial diagnostic uncertainty (9 February, 2012)

  N Mistry, J Dixon, E Tallantyre, T Jaspan, P Morgan, P Morris, N Evangelou
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0830 Help! I've become shorter than my wife: a treatable cause of camptocormia (9 February, 2012)

  S Slaght, I Galea, S O'Connell, S R Hammans
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0842 Episodic loss of consciousness in the toilet (9 February, 2012)

  J Panicker, C Mclaughlin, J Seth, S Eriksson, C Fowler, M Walker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0854 Camptocormia: what is the cause? (9 February, 2012)

  K M Doherty, L Silveira-Moriyama, A Nisbet, A Noyce, N Quinn, M Parton, A J Lees
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0906 A new clinical variant of the post-malaria neurological syndrome (9 February, 2012)

  A Pace, S Edwards
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 0918 Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): no evidence for antibodies to neuronal surface antigens (9 February, 2012)

  P Maddison, P Gozzard, T Jaspan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 001 Cognitive function in Friedreich's ataxia patients in Ireland (9 February, 2012)

  C Albertyn, N Austin, R P Murphy
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 002 Detecting retinal changes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) using optical coherence tomography (OCT) (9 February, 2012)

  P Giunti, S Nethisinghe, L M Clayton, S Vermeer, J P Chapple, M M Reilly, F Bremner
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 003 Adult-onset cerebellar ataxia due to mutations in the CABC1/ADCK3 gene (9 February, 2012)

  P O Horvath, B Czermin, S Gulati, A Pyle, A Hassani, C Foley, R W Taylor, P F Chinnery
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 004 Ataxic hemiparesis: a lacunar syndrome? Lessons from the front line (9 February, 2012)

  J Anderson, T A T Hughes
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 005 Intravenous thrombolysis in acute ischaemic stroke: experience in a developing country (9 February, 2012)

  K Dey
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 006 Derivation and evaluation of thresholds for tissue at risk in stroke using CT perfusion (9 February, 2012)

  F McVerry, N Macdougall, J M Wardlaw, M J Macleod, K W Muir
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 007 Reading broadens the mind (but may short-circuit the brain) (9 February, 2012)

  A Pace, A Smith, M Sadler, S Weatherby
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 008 Developmental venous anomaly thrombosis: case report and review of the literature (9 February, 2012)

  C M Pennington, J Battacharya, S Razvi
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 009 A curious constellation of deficits (9 February, 2012)

  R Powell, M Hourihan, T Pickersgill, T Hughes
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 010 Moyamoya and AVM: a management dilemma (9 February, 2012)

  J Redgrave, D Chadha, U Patel, M Randall
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 011 Multifocal intracranial haemorrhage as a manifestation of reversible cerebral vasoconstriction syndrome (9 February, 2012)

  O Tuohy, C O Osman, S C Chawda, A C Chaudhuri, A M Misbahuddin
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 012 This is a case series of six patients who presented with posterior reversible encephalopathy syndrome. The aim is to understand these clinicoradiological features of PRES and its management (9 February, 2012)

  S Vijayarangam Shanmugam, S M Chong, J Wijesekara
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 013 Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional MRI study (9 February, 2012)

  D Werring, S M Gregoire, A Charidimou, N Gadapa, E Dolan, N Antoun, A Peeters, Y Vandermeeren, P Laloux, J C Baron, H R Jager
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 014 Prevalence study of skeletal muscle channelopathies in England (9 February, 2012)

  A Horga, D L Raja Rayan, E Matthews, D Fialho, R Sud, A Haworth, S Portaro, J Burge, M B Davis, M G Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 015 Identifying the cause of phenotypic variability in a family with non-dystrophic myotonia (9 February, 2012)

  D Raja Rayan, A Haworth, R Sud, S McCall, S V Tan, S Durran, M Davis, M G Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 016 A case of reversible dementia (9 February, 2012)

  K Ali, R Corkill
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 017 A network model of semantic dementia (9 February, 2012)

  P Fletcher, J D Warren
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 018 Neuroferritinopathy: a new finding in a novel disease (9 February, 2012)

  M Keogh, P Jones, A Coulthard, P F Chinnery, J Burn
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 019 Profiles of white matter degeneration in frontotemporal dementia (9 February, 2012)

  C Mahoney, M N Rossor, N C Fox, J D Warren
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 020 WITHDRAWN (9 February, 2012)
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 021 Exploring the feasibility of using a Singhalese version of the TYM test with Singhalese-speaking people: a descriptive pilot study (9 February, 2012)

  S Mendis
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 022 Voxelwise analysis of cerebral diffusion tensor imaging in prion diseases (9 February, 2012)

  M C Porter, H Hyare, E De Vita, A Thompson, A Lukic, T Yousry, P Rudge, S Mead, J Collinge, J Thornton
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 023 WITHDRAWN (9 February, 2012)
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 024 What is the clinically relevant change on the ADAS-cog? (9 February, 2012)

  J Schott, A Schrag
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 025 What are exams for? The many uses formative assessment in neurology (9 February, 2012)

  M Cossburn, N P Robertson, P E M Smith
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 026 Universidade Catholica de Mozambique (UCM), Beira: the second medical school in Mozambique (9 February, 2012)

  M Evans, M P Lunn, K Steidel, J Stam, J L Day, H Manji
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 027 The cost of long neurology inpatient stays (9 February, 2012)

  T Jenkins, B S Sharrack
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 028 Resurrecting the long case (9 February, 2012)

  J A Johnston, M Hill
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 029 Neurology input for acute medical admissions (9 February, 2012)

  M Jones, M Kellett, C Murphy
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 030 Variations in grading referral letters from primary care to a neurology department (9 February, 2012)

  A Kheder, B Sharrack, J Bowen
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 031 E-learning in epilepsy (9 February, 2012)

  A E Ferris, C Lawthom
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 032 Neurologists making a difference in the ERU (9 February, 2012)

  J P Leach, I Morrison, P Shah
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 033 A systematic review of neurophobia and perceived causes among medical students and junior doctors (9 February, 2012)

  M McCarron
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 034 A systematic review of neurology education interventions (9 February, 2012)

  M McCarron
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 035 The TOS study: can we use our patients to help improve the quality of neurological referral? (9 February, 2012)

  C Yap, J Appleton, D Crossley, D J Nicholl
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 036 The TOS study: can we improve the ophthalmological assessment of medical patients by foundation year doctors? (9 February, 2012)

  V Cahill, E Willetts, D Nicholl
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 037 A data-driven assessment of the proposed criteria for classification of primary progressive aphasia (9 February, 2012)

  S A Sajjadi, K Patterson, M Tomek, R J Arnold, P J Nestor
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 038 Referral patterns to neurology: past, present and future (9 February, 2012)

  L Ridsdale, S Mtandabari, A Noble
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 039 In-patient delirium referrals to neurology from a District General Hospital (9 February, 2012)

  R Walters
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 040 Electronic neurology referrals: a solution for an overburdened healthcare system? (9 February, 2012)

  L Williams, C McGuigan, S O'Riordan, M Hutchinson, N Tubridy
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 041 The use of prolonged EEG recording in the diagnosis and clinical management of epilepsy (9 February, 2012)

  F Javaid, T Tidswell, H Angus-Leppan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 042 A critical analysis of studies of antiepileptic drugs (AEDs) and pregnancy. Maternal safety is neglected (9 February, 2012)

  H Angus-Leppan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 043 Myth-busting in non epileptic attacks: two cases of confirmed lateral tongue biting (LTB) in non-epileptic attacks (9 February, 2012)

  F Baig, S Singhal
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 044 Myth-busting in non-epileptic attacks: we present 2 cases where non-epileptic attacks caused significant burns injuries (9 February, 2012)

  F Baig, S Singhal
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 045 EEG phase coupling and network properties are abnormal in idiopathic generalised epilepsy patients and their relatives (9 February, 2012)

  F Chowdhury, T H B Fitzgerald, L Nashef, R D C Elwes, M P Richardson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 046 EAST syndrome: probable closure in many an adult case (9 February, 2012)

  D K Gandhi, S Philip, S Agrawal, E Wassmer, R Gupta
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 047 Convulsive epilepsy in a rural district of northern Tanzania: risk factors and classification (9 February, 2012)

  E Hunter, J Rogathe, A Iqbal, D Birchall, R Whittaker, M Jackson, A Jusabani, E Aris, R Walker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 048 Lost in translation: epilepsy in KwaZulu Natal South Africa (9 February, 2012)

  J A Johnston
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 049 The association between seizure activity and neural injury following endotoxin exposure and hypoxic-ischaemic insults in a preterm ovine model (9 February, 2012)

  M Keogh, P Drury, L C Booth, S Maathi, J Davidson, L Bennet, A J Gunn
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 050 Don't judge a fall by its twitch (9 February, 2012)

  A Laffan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 051 Valproate and the risk for congenital malformations; is formulation and dosage regime important? (9 February, 2012)

  E Mawhinney, J Campbell, J Craig, A Russell, W Smithson, L Parsons, I Robertson, B Irwin, P Morrison, B Liggan, N Delanty, S Hunt, J Morrow
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 052 Exploring the genetic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery (9 February, 2012)

  N Mirza, O Vasieva, A G Marson, M Pirmohamed
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 053 The characteristics of emergency attendees for epilepsy in London hospitals (9 February, 2012)

  A Noble, L H Goldstein, P Seed, P McCrone, M Morgan, L Ridsdale
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 054 Can randomised controlled trial data from non-epilepsy indications be included in meta-analysis for AEDs used in epilepsy? An analysis of adverse event data (9 February, 2012)

  A Shukralla, C Tudur-Smith, A G Marson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 055 Audit of the use of array CGH in epilepsy patients seen at a tertiary clinic (9 February, 2012)

  M Srikantha, L Nashef
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 056 Variability in adult epilepsy prevalence in the UK (9 February, 2012)

  R H Thomas, S Steer, T R Gilpin, J C D Glasbey, W H King, P E M Smith
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 057 Has a pay for performance strategy in primary care improved epilepsy management in the UK? (9 February, 2012)

  J C D Glasbey, T R Gilpin, S Steer, R H Thomas, P E M Smith
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 058 Pre-surgical evaluation in focal cortical dysplasia: a role for EEG-fMRI? (9 February, 2012)

  R Thornton, S Vulliemoz, R Rodionov, D W Carmichael, U J Chaudhary, A W McEvoy, B Diehl, M C Walker, M Guye, F Bartolomei, J S Duncan, L Lemieux
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 059 HSV1 Encephalitis as a postoperative complication of neurosurgical intervention (9 February, 2012)

  K Ali, M Prevett, E Pelosi
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 060 Ethics and neurology (9 February, 2012)

  K Baker, T A T Hughes
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 061 Central pontine myelinolysis: a CNS manifestation of re-feeding syndrome? (9 February, 2012)

  P Bose
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 062 The mischievous painter: an illustrated case of post malaria neurological syndrome (9 February, 2012)

  L Canham, C J S Price, W G Guevarra, R G Corkill
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 063 WITHDRAWN (9 February, 2012)
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 064 An unusual cause of myelopathy in neurofibromatosis type one (9 February, 2012)

  J Ealing, C Soh, J Eelloo, S Huson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 065 Obstructive hydrocephalus presenting primarily as a corpus callosum disconnection syndrome: a case report (9 February, 2012)

  I Imam, J Palmer
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 066 The paradoxical response: the development of intracranial tuberculomas during treatment for tuberculous meningitis (9 February, 2012)

  G Kennedy, S Meissner, P Lyons
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 067 Keys and locks (9 February, 2012)

  P M E Slade, C Lawthom
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 068 Lumbar puncture (9 February, 2012)

  M Flower
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 069 Introduction of a simple lumbar puncture pack to a busy medical admissions unit improves diagnosis of central nervous system infections (9 February, 2012)

  B Michael, G Powell, S Hatch, L Bailey, S Almond, S Nightingale, D Cousins, I J Hart, M Griffiths, T Solomon
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 070 Avoiding ANCAs becoming routine: the use of clinical guidelines for requesting anti-neutrophil cytoplasmic antibodies in neurology (9 February, 2012)

  J Hampton, R Ward, L Morgan, J A L Miller
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 071 Neuropsychological effects of sleep disturbance in healthy subjects (9 February, 2012)

  A Moriarty, K Anderson, P Gallagher, R H McAllister-Williams
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 072 Lumbar puncture audit: do atraumatic needle matter? (9 February, 2012)

  T Peukert, R Forbes, O Gray
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 073 Hereditary spastic paraplegia caused by spastin (SPAST, SPG4) mutations is found more often in males: report of novel mutations from one centre, and review of published literature (9 February, 2012)

  C Proukakis, D Moore, R Labrum, N W Wood, H Houlden
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 074 Rating papilloedema: an evaluation of the Frisen classification in idiopathic intracranial hypertension (9 February, 2012)

  A Sinclair, M A Burdon, P G Nightingale, T D Matthews, A Jacks, M Lawden, A Sivaguru, B J Gaskin, C E Clarke, A Ball
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 075 Herpes Simplex retinitis in a patient with prior Herpes Simplex encephalitis (9 February, 2012)

  J Stevens, E Herbert, S Johnston, E Fathers
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 076 Family history of disease is more accurate in women than men: a potential explanation for apparent gender differences in heritability of stroke (9 February, 2012)

  S Campbell, H Edwards, C Sudlow
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 077 Ectopic endometriosis in neurological practice (9 February, 2012)

  J Vanderpol
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 078 An unusual multiple radiologic findings of sub acute on chronic subdural haematoma: a case report (9 February, 2012)

  J Wong
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 079 Defective regeneration of oxidatively-inactivated 2-cys peroxiredoxins in SOD1-related Amyotrophic Lateral Sclerosis (9 February, 2012)

  S Rajan, P Shaw, C Wood-Allum
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 080 La maladie anglaise: a case of Neurosyphilis in a HIV-negative patient (9 February, 2012)

  B Wright, M B D Davies
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 081 An unusual cause of migraine: two cases and a review of the literature (9 February, 2012)

  K Ali, L Kinton, S Barker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 082 Non-invasive measurements of intracranial pressure: Can Coherent averaging show a tilt-dependent change in the measured Spontaneous Tympanic Membrane Displacement (STMD) signal in healthy volunteers? (9 February, 2012)

  J D Davids, A A Birch, R J Marchbanks
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 083 What is the aetiology of thunderclap headache? A systematic review of the causes of acute severe headache (9 February, 2012)

  E Devenney, O Gray, R Forbes
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 084 Chronic migraine: personal experience (9 February, 2012)

  G Elrington
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 085 Isolated cortical vein thrombosis: a report of seven cases (9 February, 2012)

  W Mowafi, T Patankar, T Thirugnana-Chandran, T Goddard, J Bamford, A Hassan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 086 The utility of different imaging modalities in the acute evaluation of venous sinus thrombosis (9 February, 2012)

  A Rossor, B Talbot, C D Good
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 087 The effect of antihypertensive treatment on headache and blood pressure variability in randomised controlled trials: a systematic review (9 February, 2012)

  A Webb, P M Rothwell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 088 Multifocal motor neuropathy in association with sarcoidosis (9 February, 2012)

  S Chaal
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 089 Delayed primary CNS post-transplant lymphoproliferative disorder (PTLD) (9 February, 2012)

  S K Chhetri, R Dayanandan, J Joseph, A Armour, H Sonwalkar, H C A Emsley
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 090 The phenotype of Voltage Gated Potassium Channel (VGKC) antibody positive patients at the Walton Centre for neurology and neurosurgery. A retrospective analysis of 52 patients (9 February, 2012)

  S Huda, S Wong, M J Steiger
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 091 A forgotten cause of mononeuritis multiplex (9 February, 2012)

  S Huda, G Hunter, A Krishnan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 092 A case of necrotising sarcoid granulomatosis involving the central nervous system (9 February, 2012)

  Y Liang
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 093 Extensive persistent post-ictal MRI changes: unusual imaging findings in autoimmune encephalitis (9 February, 2012)

  A Macleod, K A Dani, C Santosh, J P Leach
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 094 Anti-NMDA receptor antibodies disrupt cortical network activity in vitro (9 February, 2012)

  A Thouin, K Bera, A Vincent, M O Cunningham
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 095 A cupric pregnancy: thirteenth time lucky (9 February, 2012)

  T Young, G Downey, M B Maheshwari, D J Nicholl
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 096 Inclusion body myositis: a diagnostic challenge (9 February, 2012)

  S Brady, W Squier, D Hilton-Jones, C Sewry, J L Holton
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 097 Valosin Containing Protein (VCP) and Myofibrillar Myopathies (MFM) genes' mutations are not associated with sporadic Inclusion Body Myositis (sIBM) (9 February, 2012)

  P Machado, J Hudson, A Miller, J Morrow, M Parton, K Bushby, M Hanna
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 098 Developing new therapeutic strategies for inclusion body myositis (9 February, 2012)

  A Miller, M Ahmed, M G Hanna, L Greensmith
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 099 Erythrocyte entrapped thymidine phosphorylase (EE-TP) therapy for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) (9 February, 2012)

  N Moran, B E Bax, M D Bain
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 100 Anti-retroviral exposure and somatic mitochondrial DNA mutations (9 February, 2012)

  B A I Payne, G Pfeffer, D A Price, P F Chinnery
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 101 Systematic review of controlled trials in the treatment of mitochondrial disorders (9 February, 2012)

  G Pfeffer, D Thorburn, D Turnbull, K Majamaa, P F Chinnery
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 102 Dopamine dysregulation: not all bad news? (9 February, 2012)

  R Ali, M J Steiger, S H Alusi
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 103 Computer assisted diagnosis and monitoring of Parkinson's disease (9 February, 2012)

  J Alty, S Jamieson, S Smith
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 104 Accuracy of objective handwriting assessment for differentiating Parkinson's disease from tremulous Subjects Without Evidence of Dopaminergic Deficits (SWEDDs): an FP-CIT validated study (9 February, 2012)

  P Bain, L Wang, V K Gontu, N P S Bajaj
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 105 A case of resolving, levodopa responsive, asymmetric Parkinsonism (9 February, 2012)

  K Muhammed, P Bain
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 106 Reversible dystonia induced by cervical myelopathy: a case report (9 February, 2012)

  K Bray, S Chhetri, A Varma, M Silverdale
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 107 Longitudinal evaluation of excessive daytime sleepiness and its risk factors in Parkinson's disease (9 February, 2012)

  D P Breen, J R Evans, C H Williams-Gray, S L Mason, T Foltynie, R A Barker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 108 Investigating the neuroprotective properties of Δ9-THC in a cell culture model of Parkinson's disease (9 February, 2012)

  M Zeissler, C B Carroll, C O Hanemann, J P Zajieck
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 109 The role of dopamine in memory consolidation: evidence from patients with Parkinson's disease (9 February, 2012)

  E Coulthard, R Bogacz, D Tsivos, L Hasson, A Whone
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 110 Narcolepsy: Is it a sequelae of auto-immune encephalitis/encephalitis lethargica? (9 February, 2012)

  D K Gandhi, S Agrawal, L M Notghi, E Wassmer
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 111 Multiple necrotic ulcers resulting from subcutaneous apomorphine infusion (9 February, 2012)

  J Ganesalingam, P G Bain
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 112 Is cognition stable in progressive supranuclear palsy after diagnosis, or are we testing the wrong thing? (9 February, 2012)

  B Ghosh, J R Hodges, J B Rowe
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 113 The risk and gamble we take with our patients on dopamine agonists (9 February, 2012)

  J A Johnston, M Hill
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 114 Subacute axonal and demyelinating peripheral neuropathy complicating Duodopa therapy for Parkinson's disease (9 February, 2012)

  C Kobylecki, A G Marshall, D Gosal, M A Silverdale, M W Kellett
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 115 Systematic review of biomarkers for disease progression in Parkinson's disease (9 February, 2012)

  D McGhee, C E Counsell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 116 Serotonergic function in early Parkinson's disease with and without depression: a pilot study (9 February, 2012)

  E Newman, T C Khoo, J Patterson, J Cavanagh, S Pimlott, K A Grosset, D G Grosset
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 117 Diagnostic FP-CIT SPECT and clinical progression in Parkinson's disease (9 February, 2012)

  E Newman, L Ramani, J Patterson, T Nissen, K A Grosset, D G Grosset
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 118 The new Bradykinesia Akinesia Incoordination (BRAIN) test: an online test of upper limb movement (9 February, 2012)

  A Noyce, C Treacy, C Budu, J Fearnley, A J Lees, G Giovannoni
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 119 A pilot study of an algorithm designed to identify Parkinson's disease in the early, non-motor phase (9 February, 2012)

  A Noyce, L Silveira-Moriyama, A J Lees, A Schrag, J Bestwick, C H Hawkes, G Giovannoni, J Hardy, C H Knowles
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 120 An algorithm to identify individuals at high-risk of Parkinson's disease in the community (9 February, 2012)

  A Noyce, J Bestwick, C H Hawkes, C H Knowles, J Hardy, A J Lees, L Silveira-Moriyama, G Giovannoni, A Schrag
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 121 ARSACS: a novel phenotype causing peripheral neuropathy, ataxia and spasticity with supranuclear gaze palsy, myoclonus and epilepsy (9 February, 2012)

  J Stevens, S M Murphy, I Davagnanam, R Phadke, F Bremner, G Anderson, S Nethisinghe, P Giunti, M M Reilly
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 122 Functional correlates of abnormal temporal discrimination in adult onset primary torsion dystonia patients and first-degree relatives (9 February, 2012)

  R Whelan, D Bradley, O Kimmich, S O'Riordan, R B Reilly, M Hutchinson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 123 In vivo evidence of COMT val158met functional polymorphism modulates different levels of dopamine turnover in Parkinson's disease: an 18F-dopa PET study (9 February, 2012)

  K Wu, D O'Keeffe, M Politis, G O'Keeffe, S Bose, D J Brooks, R Barker, P Piccini
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 124 When “the drugs don't work”: think NMO! (9 February, 2012)

  R Ali, A Jacob, M Boggild
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 125 Campath-1H for multiple sclerosis: a pain in the neck? (9 February, 2012)

  V Apostu, J Zajicek, J Hobart
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 126 Analysis of genotype phenotype correlation in multiple sclerosis (9 February, 2012)

  K Baker, M D Cossburn, G Ingram, C L Hirst, S Loveless, T P Pickersgill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 127 Attitudes towards end of life issues among people with MS: a 360 survey (9 February, 2012)

  M Brothwell, G Giovannoni, J Spink
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 128 Quantification of glutamate in the grey matter and its relationship with cognitive performance in multiple sclerosis (9 February, 2012)

  N Muhlert, M Atzori, E De Vita, D Thomas, J J Geurts, C A Wheeler-Kingshott, A J Thompson, O Ciccarelli
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 129 Serum IL-21 as a biomarker in multiple sclerosis (9 February, 2012)

  M Cossburn, K E Baker, G Ingram, T P Pickersgill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 130 A pilot study of a timed short addition test as a tool for the longitudinal study of cognitive dysfunction in multiple sclerosis (9 February, 2012)

  M Cossburn, P Moore, K E Baker, T P Pickersgill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 131 Do siblings of people with multiple sclerosis (MS) have markers of MS risk? (9 February, 2012)

  R Dobson, U C Meier, K Schmierer, G Giovannoni
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 132 Treatment of neuromyelitis optica with azathioprine (9 February, 2012)

  L Elsone, M I Leite, R Brown, B McNeillis, J Palace, Boggild, M A Jacob
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 133 Aquaporin 4 antibody seropositivity and visual function in a UK cohort (9 February, 2012)

  J George, J Kitley, M I Leite, A Jacob, M Boggild, J Elston, J Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 134 Group-based cognitive behavioural approach to managing fatigue in multiple sclerosis is effective: a multi-centre parallel arm randomised controlled trial (9 February, 2012)

  S Thomas, P W Thomas, P Kersten, R Jones, C Green, A Nock, V Slingsby, C E M Hillier, K Galvin, R Baker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 135 Closing the audit loop: the hidden symptoms in multiple sclerosis (9 February, 2012)

  M Housden, M Desai, E Davis
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 136 Initial experience of alemtuzumab for patients who fail natalizumab therapy (9 February, 2012)

  S Kelly, M Duggan, K Kinsella, M Hutchinson, N Tubridy, C McGuigan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 137 Sustained freedom from disease activity over 3 years in an Irish Cohort with highly active Multiple Sclerosis (9 February, 2012)

  S Kelly, K Kinsella, M Duggan, M Hutchinson, N Tubridy, C McGuigan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 138 Differences in outcomes in neuromyelitis optica between a Japanese cohort and a predominantly Caucasian cohort from the UK (9 February, 2012)

  J Kitley, M I Leite, P Waters, B McNeillis, R Brown, Y Takai, A Jacob, M Boggild, I Nakashima, A Vincent, J Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 139 Comparison of histological and diffusion-weighted MRI techniques in the analysis of post mortem multiple sclerosis brains (9 February, 2012)

  J Kolasinski, C J Stagg, S Chance, M Esiri, E Chang, J A Palace, J A McNab, M Jenkinson, K Miller, H Johansen-Berg
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 140 Pilot MRI study of white matter changes in rheumatoid patients who have had anti-TNFα therapy (9 February, 2012)

  S Y Lim, C R Tench, M Abaei, D P Auer, C S Constantinescu
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 141 Can MRI be used as a diagnostic tool in neuromyelitis optica spectrum disorder? (9 February, 2012)

  L Matthews, A Brazier, S H Kolind, M I Leite, H Johansen-Berg, J A Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 142 Relapse frequency and depression ratings in a community sample of relapsing multiple sclerosis patients (9 February, 2012)

  P Moore, H Clarkson, K E Baker, S Luppe, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 143 Predictors of depression 6 months following MS relapse (9 February, 2012)

  P Moore, C L Hirst, H Clarkson, K L Baker, S Luppe, T P Pickersgill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 144 Case report of severe reactivation of multiple sclerosis in a patient who had recently discontinued Natalizumab and who did not have progressive multifocal encephalopathy (PML) (9 February, 2012)

  W Mowafi, O Lily, H Ford
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 145 Optico-spinal demyelination: not NMO or MS, what is it? A longitudinal cohort study (9 February, 2012)

  J Panicker, K Das, M Boggild, A Jacob
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 146 WITHDRAWN (9 February, 2012)
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 147 The effects of relapses and disability on resource use in a multidisciplinary MS clinic (9 February, 2012)

  I Pomeroy, M Calabresi, C A Young
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 148 The effect of natalizumab and interferon-β on urinary free light chains and anti-EBV nuclear antigen-1 antibodies in relapsing remitting multiple sclerosis (9 February, 2012)

  J Raffel, R Dobson, G Giovannoni
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 149 The national diagnostic and advisory service for NMO: an overview of the service (9 February, 2012)

  J Revis, K Mutch
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 150 Cost of spasticity associated with multiple sclerosis in the UK (9 February, 2012)

  V Stevenson, A Latour, J Broughton, A Lloyd
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 151 A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen City (9 February, 2012)

  E Visser, K Wilde, K K Yong, J F Wilson, C E Counsell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 152 Are neurophysiological parameters an objective measure of disease status and progression in primary progressive multiple sclerosis? (9 February, 2012)

  J Witherick, N Kane, S Butler, P Walsh, K Blake, H Faulkner, J Burrows, K Inglis, D Cottrell
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 153 A common disease but a rare cause of lumbosacral plexopathy (9 February, 2012)

  R Ali, F Torella, H Nahser, R Davies
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 154 The natural history of motor neurone disease (MND): assessing the impact of specialist care (9 February, 2012)

  T Aridegbe, R Kandler, T Walsh, P J Shaw, C J McDermott
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 155 A case series; a Miller Fisher Syndrome epidemic (9 February, 2012)

  S Banik, J A Johnston, N P Hinds, J Walters, M Hill
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 156 Motor neurones subtypes resistant to degeneration in amyotrophic lateral sclerosis show distinct synaptic characteristics across species (9 February, 2012)

  A Brockington, K Ning, P Heath, E Wood, K Malik, N Fusi, S Wharton, P G Ince, P J Shaw
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 157 The epidemiology of congenital myasthenic syndromes in Northern Ireland (9 February, 2012)

  A Carr, C Cardwell, D O'Reilly, P O McCarron, J McConville
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 158 Why can't I win any more? (9 February, 2012)

  R Dobson, G Giovannoni
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 159 Dysregulation of the cross-talk with astrocytes as a contributory factor to motor neuron injury in motor neuron disease (9 February, 2012)

  L Ferraiuolo, A Higginbottom, P R Heath, S Barber, D Greenald, J Kirby, P J Shaw
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 160 Novel in vitro and in vivo models of ALS associated with TDP-43 proteinopathy (9 February, 2012)

  C Hewamadduma, C A A Higgenbottom, C Moens, K Helde, R Raman, R Tennore, A Grierson, P J Shaw
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 161 15–30 Hz intermuscular coherence as a potential biomarker of upper motor neuron dysfunction in motor neuron disease (9 February, 2012)

  S Jaiser, K M Fisher, B Zaaimi, H Seow, J A L Miller, P F Chinnery, T L Williams, S N Baker, M R Baker
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 162 The association of two rare neurological diseases: a multicentre study of 16 patients with AChR antibody myasthenia gravis and AQP4 antibody neuromyelitis optica spectrum disorder (9 February, 2012)

  M I Leite, E Coutinho, D Callegaro, M Lana-Peixoto, P Waters, D Sato, L Melamud, A Graham, A Vincent, J Palace
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 163 Inflammatory demyelinating neuropathy complicating anti-TNF-α therapy (9 February, 2012)

  E Marsh, T Young, K Morrison, J B Winer, J G Llewelyn
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 164 Experience of the use of diaphragm pacing in patients with respiratory impairment due to motor neurone disorders (9 February, 2012)

  C McDermott, A Proctor, T Walsh, R Ackroyd, G Rao, S Bianchi, L Englert, M K Rafiq, P J Shaw
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 165 Novel ANO5 gene mutations, c.989dupT and c.2018A→G causing Limb Girdle Muscular dystrophy 2L (9 February, 2012)

  J Panicker, H Lochmuller, K Bushby, V Straub, D Hicks, A Sarkozy, P Ray
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 166 The heat is “ON” in the Neurons: neuronal stress in a sod1 Zebrafish model of MND affects neuromuscular junction integrity and causes muscle denervation (9 February, 2012)

  T Ramesh, A McGown, S Al Mashhadi, N Redhead, A Lyon, C E Bettie, P J Shaw
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 167 An in-vitro study of distal hereditary motor neuropathy due to homozygous HSJ1 mutations (9 February, 2012)

  A Rossor, B Kalmar, A Gray, W Mustill, G Schiavo, M E Cheetham, M M Reilly, L Greensmith, S Novoselov
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 168 Rituximab in the treatment of Multifocal Acquired Demyelinating Sensory and Motor Neuropathy (MADSAM) (9 February, 2012)

  P Shanmugarajah, D G Rao, M Hadjivassiliou
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 169 Antisaccade task as a biomarker in MND (9 February, 2012)

  R Sharma, S Hicks, C Berna, C Kennard, K Talbot, M R Turner
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 170 Diaphragmatic weakness following thymectomy: due to myasthenia gravis or phrenic nerve injury? (9 February, 2012)

  J Spillane, N P Hirsch, D M Kullmann, R S Howard
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 171 Myasthenic crisis in the intensive care unit: a 10-year review (9 February, 2012)

  J Spillane, C Taylor, N P Hirsch, D M Kullmann, R S Howard
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 172 An unusual case of congenital myasthenic syndrome: the mechanism for treatment response (9 February, 2012)

  J Spillane, D M Kullmann, D Beeson, R S Howard
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 173 Footfalls echo in the memory (9 February, 2012)

  W O Tobin, M Farrell, C McGuigan
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 174 Horizontal saccade slowing in a patient with facial onset sensory and motor neuronopathy (FOSMN) (9 February, 2012)

  J Walters
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 175 A disappearing act: a tale of immunosuppression, EBV and CNS B-cell lymphoma (9 February, 2012)

  C Doherty, S J Hunt, P Toner, O M Sheehy, E Healy
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 176 Intravascular B cell lymphoma: a case series (9 February, 2012)

  K Kendall, R H Thomas, G A Lammie, J W Neal, R G Corkill, N P Robertson
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 177 Measuring cognitive function in people with brain tumours using the Addenbrooke's Cognitive Examination (9 February, 2012)

  S Kerrigan, A Rooney, R Grant
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 178 “A different kettle of fish”: a journey looking for the cause of paraneoplastic limbic encephalitis (9 February, 2012)

  T Mihalova, T Young, D Gey van Pittius, C C Moor
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 179 A delayed diagnosis of mistaken mitosis (9 February, 2012)

  A Pace, M Sadler
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 180 The smell of danger (9 February, 2012)

  A Pace, M Sadler
• Abstracts from the Association of British Neurologists Annual Meeting 2011: 181 National Institute for Health Research leading the way for Neurosciences Research (9 February, 2012)

  C Rhymes